-transparent.png){kind=logo}
Thirty-three patients with pityriasis rosea were studied with regard to the possible presence of circulating and cutaneously deposited immune complexes. The levels of circulating immune complexes, determined by a solid-phase C1q-binding assay, were not different from those of healthy control individuals. The levels were similar in samples obtained during the initial and during the remission stages of the disease. Cutaneous deposits of immunoglobulin and/or complement were found in only 5 of 33 patients. This study does not support of concept that circulating immune complexes are important for the development of the secondary skin lesions in pityriasis rosea.
Related Publications
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
December 1984,
The Journal of dermatology,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
May 1946,
Archives of dermatology and syphilology,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
October 1977,
Archives of dermatology,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
January 2022,
Proceedings (Baylor University. Medical Center),
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
January 2014,
Journal of the American Academy of Dermatology,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
September 2018,
JAAD case reports,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
April 2014,
Annales de dermatologie et de venereologie,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
March 2021,
Dermatology reports,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
May 2001,
Annales de dermatologie et de venereologie,
H Mobacken, and
L M Bjursten, and
G B Löwhagen, and
L A Nilsson
April 1985,
Cutis,
